United Therapeutics (NASDAQ:UTHR) reported earnings of $5.57 per share beating Walls Streets expectations.

ME Staff
-
0

United Therapeutics (NASDAQ:UTHR) reported Q1 2018 earnings this Morning, coming in at $5.57 per share, beating Wall Street’s estimates of $3.62 per Share. Revenue for the quarter came in at $389.20 million missing the streets estimates of $393.96 million

Recent Insider Trading for United Therapeutics (NASDAQ:UTHR)

  • On 4/9/2018 Martine A Rothblatt, CEO, sold 21,513 with an average share price of $110.88 per share and the total transaction amounting to $2,385,361.44.
  • On 4/5/2018 Martine A Rothblatt, CEO, sold 21,512 with an average share price of $114.30 per share and the total transaction amounting to $2,458,821.60.
  • On 4/3/2018 Martine A Rothblatt, CEO, sold 22,059 with an average share price of $114.44 per share and the total transaction amounting to $2,524,431.96.
  • On 3/29/2018 Martine A Rothblatt, CEO, sold 43,024 with an average share price of $111.14 per share and the total transaction amounting to $4,781,687.36.
  • On 3/22/2018 Martine A Rothblatt, CEO, sold 1,100 with an average share price of $110.01 per share and the total transaction amounting to $121,011.00.
  • On 3/20/2018 Martine A Rothblatt, CEO, sold 301 with an average share price of $110.48 per share and the total transaction amounting to $33,254.48.



Dividend History for United Therapeutics (NASDAQ:UTHR)



    Recent Trading for United Therapeutics (NASDAQ:UTHR)
    Shares of United Therapeutics closed the previous trading session at 112.38 up +0.71 0.64% with 111.80000305175781 shares trading hands.